Cancer treatments have come a long way, offering hope to millions of patients. One major breakthrough is the use of immune checkpoint inhibitors (ICIs), a type of therapy that helps the immune system attack cancer cells.
However, ICIs can also cause serious side effects, including a rare but dangerous condition known as ICI-related myocarditis, an inflammation of the heart that can be fatal in up to 40% of cases.
This side effect occurs when the immune system becomes too aggressive and begins attacking healthy heart tissue, with white blood cells and other immune cells flooding into the heart and causing damage.
Diagnosing this heart condition early is critical, as prompt treatment can help prevent serious harm or death.
Until now, detecting ICI-related myocarditis has been a major challenge, but a new blood test offers hope for early detection.
A new blood test detects ICI-related myocarditis, a dangerous heart side effect from cancer treatment.
Author's summary: New blood test helps detect heart side effect from cancer treatment.